Results of motor vehicles agency-administered vision tests do not necessarily reflect fitness to
drive, according to a study published in Investigative Ophthalmology & Visual Science.
Author: ModernMedecine
Fear of falling tied to glaucoma severity
NEW YORK (Reuters Health) – Visual field (VF) loss resulting from glaucoma is associated with an
increased fear of falling, even in people not classified as blind, a new study shows.
Infectious scleritis often tied to herpes virus
NEW YORK (Reuters Health) – Almost 75% of cases of infectious scleritis result from herpes virus, but
the diagnosis is often missed, a new paper warns.
Bevacizumab, aflibercept reduce macular edema due to central retinal vein occlusion
NEW YORK (Reuters Health) – Two news studies show that bevacizumab and aflibercept can reduce macular
edema and improve visual acuity in patients with central retinal vein occlusion (CRVO).
Uveitis incidence increases following herpes zoster
NEW YORK (Reuters Health) – An episode of herpes zoster is associated with an increased risk of
anterior uveitis in the following year, according to a Taiwanese report this month in Archives of
Ophthalmology.
Fluoroquinolones may increase risk of retinal detachment
Oral fluoroquinolones, one of the most commonly prescribed classes of antibiotics, may increase a
person?s risk for developing a retinal detachment, according to a study published April 4 in JAMA.
Scleral implants improve presbyopic vision
Use of a scleral implant (PresView Scleral Implant, Refocus Group) has resulted in marked improvements
in the near vision in emmetropic patients with presbyopia. The mean increase in near vision was +3.41 lines,
according to Barrie Soloway, MD,…
More counterfeit bevacizumab found
For the second time this year, the FDA has issued an alert that an injectable cancer drug purchased
from a foreign source and distributed in the United States is counterfeit.
Bevacizumab effect in diabetic macular edema sustained at two years
NEW YORK (Reuters Health) – A study conducted at Moorfields Eye Hospital in London, UK, finds that the
benefits seen at one year with bevacizumab treatment of macular edema are sustained at two years, with
comparatively few intravitreal injecti…
CDC investigates fungal endophthalmitis cases
The Centers for Disease Control and Prevention (CDC) will investigate cases of fungal endophthalmitis
that appear to be unrelated to those associated with a Florida company that led to last month’s FDA recall of
Brilliant Blue G (see Ophthalmol…
Dr. Christopher Girkin named UAB chairman
Christopher A. Girkin, MD, MSPH, has been named chairman of the Department of Ophthalmology at the
University of Alabama at Birmingham (UAB). Dr. Girkin has been interim department chairman since October and has
been on the faculty at UAB since…
Phase III corneal cross-linking study initiated
The American-European Congress of Ophthalmic Surgery (ACOS) and Avedro Inc. have announced the
initiation of a phase III, multicenter evaluation to study accelerated corneal collagen cross-linking in eyes that
have keratoconus or corneal ectasi…
Research uncovers IOP regulation in glaucoma
How aqueous humor responds to mechanical stimuli at the cellular level (mechanosensing) affects the
regulation of IOP through cells converting those stimuli into chemical activity (mechanotransduction), according to
an article published April 4…
Watson files ANDAs despite lawsuits
Watson Laboratories Inc., a subsidiary of Watson Pharmaceuticals Inc., has filed abbreviated new drug
applications (ANDAs) with the FDA seeking approval to market bimatoprost ophthalmic solution 0.01% and bimatoprost
ophthalmic solution 0.03%.
MitoChem gets $2 million for retina research
The Foundation Fighting Blindness has made a $2 million investment in MitoChem Therapeutics to develop
a cross-cutting treatment for degenerative diseases of the retina.
Optos ships next-generation imaging devices
Medical retinal imaging company Optos plc has delivered its first next-generation ultra-widefield
retinal imaging devices (Daytona) to customers. The new devices have been scaled to accommodate smaller office
spaces while providing high-resolut…
Athletes focus of Sports Eye Safety Month
During Sports Eye Safety Month in April, the American Academy of Ophthalmology, through its EyeSmart
program, is reminding athletes to wear appropriate, sport-specific protective eyewear, properly fitted by an
eye-care professional, to prevent …
Look deep into women’s eyes in April
Prevent Blindness America (PBA) has designated April as Women’s Eye Health and Safety
Month.
Oral bisphosphonates linked to ocular side effects
NEW YORK (Reuters Health) – A Canadian study confirms an increased risk of uveitis and scleritis in
first-time users of oral bisphosphonates.
Investigational DME agent nears phase II trial
iCo Therapeutics and JDRF, formerly the Juvenile Diabetes Research Foundation, have joined forces in a
phase II clinical trial to investigate the investigational drug iCo-007 as a treatment for diabetic macular edema
(DME).